Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Yıl: 2022 Cilt: 33 Sayı: 10 Sayfa Aralığı: 838 - 843 Metin Dili: İngilizce DOI: 10.5152/tjg.2022.21726 İndeks Tarihi: 25-10-2022
Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Öz: Background: We aimed to determine the awareness of referring hepatitis C virus patients to the relevant departments and the effect of the pandemic period on this subject. Methods: A total of 65 743 patients with anti-hepatitis C virus requests before and during the COVID-19 pandemic were retrospectively screened. Anti-hepatitis C virus-positive patients were divided into 5 groups according to age distribution. The distribution of patients with anti-hepatitis C virus positivity was compared according to age groups, before and during COVID-19. Anti-hepatitis C virus-positive patients who were not requested hepatitis C virus RNA were evaluated individually according to the departments, and hepatitis C virus awareness was compared before and during COVID-19. Results: Anti-hepatitis C virus positivity rate was 1.54% before COVID-19; this rate was 2.15% during COVID-19. When the anti-hepatitis C virus positivity rate was compared in terms of age distribution according to before and during COVID-19, it was observed that there was a statistically significant decrease in the >65 age group in the COVID-19 period (P = .004). It was found that 216 (32%) of the patients who had anti-hepatitis C virus (+) before COVID-19 and 231 (48.1%) of the patients during COVID-19 were not requested hepatitis C virus RNA test (P < .0001). The departments with the highest awareness of hepatitis C virus were gastroenterology, infectious diseases, hematology, gynecology and obstetrics, and oncology, while the departments with the lowest hepatitis C virus awareness were ophthalmology, psychiatry, and general surgery. It was found that chronic hepatitis C virus awareness decreased in all departments during COVID-19. Conclusion: Hepatitis C virus awareness has decreased in all medical departments despite the physician alert system during COVID-19 and also the rate of anti-hepatitis C virus (+) patients decreased in the group aged >65 years during the pandemic.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Shire NJ, Sherman KE. Epidemiology of hepatitis C virus: a battle on new frontiers. Gastroenterol Clin North Am. 2015;44(4):699-716. [CrossRef]
- 2. Seeff LB. The history of the “natural history” of hepatitis C (1968- 2009). Liver Int. 2009;29(suppl 1):89-99. [CrossRef]
- 3. Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virüs infection: a meta-analysis and meta-regression. Hepatology. 2008;48(2):418- 431. [CrossRef]
- 4. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virüs infection. J Hepatol. 2014;61(1)(suppl):S45-S57. [CrossRef]. Epub: July 30, 2014.
- 5. Polaris Observatory HCVC. Global prevalence and genotype distribution of hepatitis C virüs infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161-176.
- 6. Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: a Lancet gastroenterology and Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4(2): 135-184. [CrossRef]
- 7. World Health Organization. Global health sector strategy on viral hepatitis 2016-2021; 2016. Available at: http://apps.who.int/iris/ bitst ream/ 10665 /2461 77/1/ WHO-H IV-20 16.06 -eng. pdf. Accessed June 2016.
- 8. Centers for Disease Control and Prevention. Surveillance for viral hepatitis United States; 2016. Available at: https ://ww w.cdc .gov/ hepat itis/ stati stics /2016 surve illan ce/co mment ary.h tm. Accessed April 16, 2018.
- 9. Global hepatitis programme WHO/HIV/2016.06. Available at: https://apps.who.int/iris/bitstream/handle/10665/246177/WHOHIV- 2016.06-eng.pdf?sequence=1&isAllowed=y.
- 10. Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-76. [CrossRef]
- 11. Healthcare facilities: managing operations During the COVID-19 pandemic. Available at: https://www.cdc.gov/coronavirus/2019-ncov/ hcp/facility-planning-operations.html. Accessed August 18, 2020. 12. Blach S, Kondili LA, Aghemo A, et al. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2021;74(1):31-36. [CrossRef]. Epub: August 7, 2020.
- 13. Boettler T, Marjot T, Newsome PN, et al. Impact of COVID-19 on the care of patients with liver disease: EASLESCMID position paper after 6 months of the pandemic. JHEP Rep. 2020;2:100169.
- 14. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020 Oct;89:531-542. [CrossRef]
- 15. Kaufman HW, Bull-Otterson L, Meyer WA 3rd, et al. Decreases in hepatitis C testing and treatment During the COVID-19 pandemic. Am J Prev Med. 2021;S0749-3797(21):00220-00228.
- 16. Stasi C, Silvestri C, Voller F. Update on hepatitis C epidemiology: unaware and untreated infected population could be the key to elimination. SN Compr Clin Med. 2020;2(12):2808-2815. [CrossRef]
- 17. Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: national Health and Nutrition Examination survey 2001-2008. Hepatology. 2012;55(6):1652-1661. [CrossRef]
- 18. Balaban HY, Dağ O, Alp A, et al. Retrospective evaluation of hepatitis C awareness in Turkey through two decades. Turk J Gastroenterol. 2021;32(1):88-96. [CrossRef]
- 19. Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323(24):2466-2467. [CrossRef]
- 20. Guss D, Sherigar J, Rosen P, Mohanty SR. Diagnosis and management of hepatitis C infection in primary care settings. J Gen Intern Med. 2018;33(4):551-557. [CrossRef]
- 21. Rice DP, Ordoveza MA, Palmer AM, Wu GY, Chirch LM. Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients. AIDS Care. 2018;30(12):1507- 1511. [CrossRef]
- 22. Karimi-Sari H, Rezaee-Zavareh MS. COVID-19 and viral hepatitis elimination programs: are we stepping backward? Liver Int. 2020 August;40(8):2042. [CrossRef]
- 23. Wong RJ, Campbell B, Liu B, Baden R, Bhuket T. Sub-optimal test- ing and awareness of HCV and HBV among high risk individuals at an underserved Safety-Net Hospital.
| APA | Barutcu S, Yıldırım Ç, yıldırım a, KONDUK B, Sayiner Z, Gulsen M (2022). Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. , 838 - 843. 10.5152/tjg.2022.21726 |
| Chicago | Barutcu Sezgin,Yıldırım Çiğdem,yıldırım abdullah emre,KONDUK BUĞRA,Sayiner Zeynel Abidin,Gulsen Murat Taner Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. (2022): 838 - 843. 10.5152/tjg.2022.21726 |
| MLA | Barutcu Sezgin,Yıldırım Çiğdem,yıldırım abdullah emre,KONDUK BUĞRA,Sayiner Zeynel Abidin,Gulsen Murat Taner Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. , 2022, ss.838 - 843. 10.5152/tjg.2022.21726 |
| AMA | Barutcu S,Yıldırım Ç,yıldırım a,KONDUK B,Sayiner Z,Gulsen M Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. . 2022; 838 - 843. 10.5152/tjg.2022.21726 |
| Vancouver | Barutcu S,Yıldırım Ç,yıldırım a,KONDUK B,Sayiner Z,Gulsen M Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. . 2022; 838 - 843. 10.5152/tjg.2022.21726 |
| IEEE | Barutcu S,Yıldırım Ç,yıldırım a,KONDUK B,Sayiner Z,Gulsen M "Changes in Hepatitis C Awareness in Different Disciplines During COVID-19." , ss.838 - 843, 2022. 10.5152/tjg.2022.21726 |
| ISNAD | Barutcu, Sezgin vd. "Changes in Hepatitis C Awareness in Different Disciplines During COVID-19". (2022), 838-843. https://doi.org/10.5152/tjg.2022.21726 |
| APA | Barutcu S, Yıldırım Ç, yıldırım a, KONDUK B, Sayiner Z, Gulsen M (2022). Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. Turkish Journal of Gastroenterology, 33(10), 838 - 843. 10.5152/tjg.2022.21726 |
| Chicago | Barutcu Sezgin,Yıldırım Çiğdem,yıldırım abdullah emre,KONDUK BUĞRA,Sayiner Zeynel Abidin,Gulsen Murat Taner Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. Turkish Journal of Gastroenterology 33, no.10 (2022): 838 - 843. 10.5152/tjg.2022.21726 |
| MLA | Barutcu Sezgin,Yıldırım Çiğdem,yıldırım abdullah emre,KONDUK BUĞRA,Sayiner Zeynel Abidin,Gulsen Murat Taner Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. Turkish Journal of Gastroenterology, vol.33, no.10, 2022, ss.838 - 843. 10.5152/tjg.2022.21726 |
| AMA | Barutcu S,Yıldırım Ç,yıldırım a,KONDUK B,Sayiner Z,Gulsen M Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. Turkish Journal of Gastroenterology. 2022; 33(10): 838 - 843. 10.5152/tjg.2022.21726 |
| Vancouver | Barutcu S,Yıldırım Ç,yıldırım a,KONDUK B,Sayiner Z,Gulsen M Changes in Hepatitis C Awareness in Different Disciplines During COVID-19. Turkish Journal of Gastroenterology. 2022; 33(10): 838 - 843. 10.5152/tjg.2022.21726 |
| IEEE | Barutcu S,Yıldırım Ç,yıldırım a,KONDUK B,Sayiner Z,Gulsen M "Changes in Hepatitis C Awareness in Different Disciplines During COVID-19." Turkish Journal of Gastroenterology, 33, ss.838 - 843, 2022. 10.5152/tjg.2022.21726 |
| ISNAD | Barutcu, Sezgin vd. "Changes in Hepatitis C Awareness in Different Disciplines During COVID-19". Turkish Journal of Gastroenterology 33/10 (2022), 838-843. https://doi.org/10.5152/tjg.2022.21726 |
